Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities

被引:143
作者
Shinbo, Y
Niki, T
Taira, T
Ooe, H
Takahashi-Niki, K
Maita, C
Seino, C
Iguchi-Ariga, SMM
Ariga, H [1 ]
机构
[1] Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan
[2] Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama, Japan
[3] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan
关键词
DJ-1; SUMO-1; conjugation; apoptosis; oxidative stress; cell transformation; cell growth;
D O I
10.1038/sj.cdd.4401704
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DJ-1 is a multifunctional protein that plays roles in transcriptional regulation and antioxidative stress, and loss of its function is thought to result in the onset of Parkinson's disease (PD). Here, we report that DJ-1 was sumoylated on a lysine residue at amino-acid number 130 (K130) by PIASx alpha or PIASy. The K130 mutation abrogated all of the functions of DJ-1, including ras-dependent transformation, cell growth promotion and anti-UV-induced apoptosis activities. Sumoylation of DJ-1 was increased after UV irradiation concomitant with a pl shift to an acidic point of DJ-1. Furthermore, L166P, a mutant DJ-1 found in PD patients, and K130RX, an artificial mutant containing four mutations in DJ-1, were improperly sumoylated, and they became insoluble, partly localized in the mitochondria and degraded by the proteasome system. Both L166P-expressing cells and DJ-1-knockdown cells were found to be highly susceptible to UV-induced cell apoptosis.
引用
收藏
页码:96 / 108
页数:13
相关论文
共 67 条
[1]   The role of pathogenic DJ-1 mutations in Parkinson's disease [J].
Abou-Sleiman, PM ;
Healy, DG ;
Quinn, N ;
Lees, AJ ;
Wood, NW .
ANNALS OF NEUROLOGY, 2003, 54 (03) :283-286
[2]   The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease [J].
Bandopadhyay, R ;
Kingsbury, AE ;
Cookson, MR ;
Reid, AR ;
Evans, IM ;
Hope, AD ;
Pittman, AM ;
Lashley, T ;
Canet-Aviles, R ;
Miller, DW ;
McLendon, C ;
Strand, C ;
Leonard, AJ ;
Abou-Sleiman, PM ;
Healy, DG ;
Ariga, H ;
Wood, NW ;
de Silva, R ;
Revesz, T ;
Hardy, JA ;
Lees, AJ .
BRAIN, 2004, 127 :420-430
[3]   Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism [J].
Bonifati, V ;
Rizzu, P ;
van Baren, MJ ;
Schaap, O ;
Breedveld, GJ ;
Krieger, E ;
Dekker, MCJ ;
Squitieri, F ;
Ibanez, P ;
Joosse, M ;
van Dongen, JW ;
Vanacore, N ;
van Swieten, JC ;
Brice, A ;
Meco, G ;
van Duijn, CM ;
Oostra, BA ;
Heutink, P .
SCIENCE, 2003, 299 (5604) :256-259
[4]   The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization [J].
Canet-Avilés, RM ;
Wilson, MA ;
Miller, DW ;
Ahmad, R ;
McLendon, C ;
Bandyopadhyay, S ;
Baptista, MJ ;
Ringe, D ;
Petsko, GA ;
Cookson, MR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (24) :9103-9108
[5]   Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila [J].
Chan, HYE ;
Warrick, JM ;
Andriola, I ;
Merry, D ;
Bonini, NM .
HUMAN MOLECULAR GENETICS, 2002, 11 (23) :2895-2904
[6]   Differential effects of Parkinson's disease-associated mutations on stability and folding of DJ-1 [J].
Görner, K ;
Holtorf, E ;
Odoy, S ;
Nuscher, B ;
Yamamoto, A ;
Regula, JT ;
Beyer, K ;
Haass, C ;
Kahle, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (08) :6943-6951
[7]   Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation [J].
Hague, S ;
Rogaeva, E ;
Hernandez, D ;
Gulick, C ;
Singleton, A ;
Hanson, M ;
Johnson, J ;
Weiser, R ;
Gallardo, M ;
Ravina, B ;
Gwinn-Hardy, K ;
Crawley, A ;
St George-Hyslop, PH ;
Lang, AE ;
Heutink, P ;
Bonifati, V ;
Hardy, J ;
Singleton, A .
ANNALS OF NEUROLOGY, 2003, 54 (02) :271-274
[8]   DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease [J].
Hedrich, K ;
Djarmati, A ;
Schäfer, N ;
Hering, R ;
Wellenbrock, C ;
Weiss, PH ;
Hilker, R ;
Vieregge, P ;
Ozelius, LJ ;
Heutink, P ;
Bonifati, V ;
Schwinger, E ;
Lang, AE ;
Noth, J ;
Bressman, SB ;
Pramstaller, PP ;
Riess, O ;
Klein, C .
NEUROLOGY, 2004, 62 (03) :389-394
[9]   INHIBITION OF BIOGENIC AMINE UPTAKE BY HYDROGEN PEROXIDE - MECHANISM FOR TOXIC EFFECTS OF 6-HYDROXYDOPAMINE [J].
HEIKKILA, R ;
COHEN, G .
SCIENCE, 1971, 172 (3989) :1257-&
[10]  
Hod Y, 1999, J CELL BIOCHEM, V72, P435, DOI 10.1002/(SICI)1097-4644(19990301)72:3<435::AID-JCB12>3.0.CO